Cargando…
MBNL1 regulates isoproterenol‐induced myocardial remodelling in vitro and in vivo
Myocardial remodelling is a common phenomenon in cardiovascular diseases, which threaten human health and the quality of life. Due to the lack of effective early diagnosis and treatment methods, the molecular mechanism of myocardial remodelling should be explored in depth. In this study, we observed...
Autores principales: | Xu, Yao, Liang, Chen, Luo, Ying, Zhang, Tongcun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812249/ https://www.ncbi.nlm.nih.gov/pubmed/33295096 http://dx.doi.org/10.1111/jcmm.16177 |
Ejemplares similares
-
Mbnl1 and Mbnl2 regulate brain structural integrity in mice
por: Sta Maria, Naomi S., et al.
Publicado: (2021) -
Shexiang Tongxin dropping pill protects against isoproterenol-induced myocardial ischemia in vivo and in vitro
por: Qi, Jianyong, et al.
Publicado: (2017) -
Ivabradine improves survival and attenuates cardiac remodeling in isoproterenol‐induced myocardial injury
por: Simko, Fedor, et al.
Publicado: (2020) -
Exploring cardioprotective potential of esculetin against isoproterenol induced myocardial toxicity in rats: in vivo and in vitro evidence
por: Pullaiah, Chitikela P., et al.
Publicado: (2021) -
Autoregulation of MBNL1 function by exon 1 exclusion from MBNL1 transcript
por: Konieczny, Patryk, et al.
Publicado: (2017)